These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7272012)

  • 1. Direct and serum-induced lymphocytotoxicity against rabbit hepatocytes in chronic active hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Boll Ist Sieroter Milan; 1981; 60(1):46-51. PubMed ID: 7272012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Direct and induced lymphocytotoxicity to rabbit hepatocytes in chronic active hepatitis].
    Laghi V; Cauda R; Nervo P
    Arch Sci Med (Torino); 1980; 137(4):575-7. PubMed ID: 7247672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.
    Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R
    Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathological mechanisms responsible for hepatic lesions caused by B virus].
    Vuitton D; Trepo C
    Pathol Biol (Paris); 1984 Mar; 32(3):190-8. PubMed ID: 6201804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Cauda R; Nervo P
    Clin Exp Immunol; 1979 Nov; 38(2):231-4. PubMed ID: 527260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
    Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
    Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
    Kakumu S; Hara T; Gohji H; Sakamoto N
    Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
    Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of 2 mercaptopropionylglycine on the cytotoxic activity of lymphocytes from patients with chronic active hepatitis against rabbit hepatocytes isolated and cultured in vitro].
    Mazzetti M; Guizzardi G; Meliconi R; Baraldini M; Stancari MV; Mazzoli M; Stefanini GF
    Boll Soc Ital Biol Sper; 1981 Jul; 57(14):1477-83. PubMed ID: 7295410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
    Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
    J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity in acute and chronic hepatitis.
    Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
    J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on lymphocytotoxicity in acute and chronic liver disease.
    Warnatz H; Gutmann W; Rösch W; Hommel G
    Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):435-49. PubMed ID: 602346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.
    Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G
    Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated cytotoxicity to autologous hepatocytes in HBsAg positive liver disease: an analysis of the killing specificity and of the clinical use of the test.
    Actis GC; Touscoz GA; Crivelli O; Rizzetto M; Rocca B; Poli G; Verme G
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):19-29. PubMed ID: 6206876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Affects of HBV genotypes (B/C) on the levels of serum and intrahepatic HBsAg].
    Chen JJ; Ma SW; Wang ZH; Sun J; Zhu YF; Hou JL
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1947-51. PubMed ID: 17064586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
    Bortolotti F; Realdi G; Diodati G; Fattovich G
    Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease.
    Kawanishi H; MacDermott RP
    Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte cytotoxicity for isolated hepatocytes in acute viral and chronic active hepatitis.
    Cochrane M; Eddleston A; Williams R
    Minerva Med; 1978 Aug; 69(38):2543-8. PubMed ID: 714256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.